Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Divalent anion:Na symporter (DASS) | ||||||
Solute carrier family 13 member 2 (SLC13A2) | Click to Show/Hide the Full List of Regulating Pair(s): 4 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (BI01383298) of SLC13A2 | |||||
Induced Change | Citric acid concentration: decrease (FC = 0.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that inhibition (BI01383298) of SLC13A2 leads to the decrease of citric acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Mutation (T86C) of SLC13A2 | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (T86C) of SLC13A2 leads to the decrease of citric acid levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Mutation (Y228C) of SLC13A2 | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Y228C) of SLC13A2 leads to the decrease of citric acid levels compared with control group. | |||||
Regulating Pair (4) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Mutation (Y432C) of SLC13A2 | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Y432C) of SLC13A2 leads to the decrease of citric acid levels compared with control group. | |||||
GPCR rhodopsin (GPCR-1) | ||||||
Adrenergic receptor beta-3 (ADRB3) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Agonist (CL-316,243) of Adrb3 | |||||
Induced Change | Citric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that agonist of ADRB3 leads to the increase of citric acid levels compared with control group. | |||||
Hydrolases (EC 3) | ||||||
Leukotriene-C4 hydrolase (GGT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Knockdown (siRNA) of GGT1 | |||||
Induced Change | Citric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Renal cell carcinoma [ICD-11: 2C90] | |||||
Details | It is reported that knockdown of GGT1 leads to the increase of citric acid levels compared with control group. | |||||
Oxidoreductases (EC 1) | ||||||
Alcohol dehydrogenase iron 1 (ADHFE1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Overexpression of ADHFE1 | |||||
Induced Change | Citric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that overexpression of ADHFE1 leads to the increase of citric acid levels compared with control group. | |||||
Alpha-ketoglutarate dehydrogenase (OGDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Knockout of OGDH | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
Details | It is reported that knockout of OGDH leads to the decrease of citric acid levels compared with control group. | |||||
D-beta-hydroxybutyrate dehydrogenase (BDH1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Knockdown (shRNA) of BDH1 | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that knockdown of BDH1 leads to the decrease of citric acid levels compared with control group. | |||||
Formyltetrahydrofolate dehydrogenase (ALDH1L2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[8] | ||||
Introduced Variation | Mutation of ALDH1L2 | |||||
Induced Change | Citric acid concentration: increase (FC = 2.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Genetic disorders of keratinisation [ICD-11: EC20] | |||||
Details | It is reported that mutation (patients) of ALDH1L2 leads to the increase of citric acid levels compared with control group. | |||||
Pore-forming PNC peptide (PNC) | ||||||
Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[9] | ||||
Introduced Variation | Knockout of TP53 | |||||
Induced Change | Citric acid concentration: increase (Log2 FC=1.28) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockout of TP53 leads to the increase of citric acid levels compared with control group. | |||||
Transcription factor (TF) | ||||||
Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[10] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of citric acid levels compared with control group. | |||||
Transferases (EC 2) | ||||||
Citrate synthase (CS) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[11] | ||||
Introduced Variation | Knockdown (siRNA) of CS | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of CS leads to the decrease of citric acid levels compared with control group. | |||||
Histone-lysine N-methyltransferase 2D (KMT2D) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[12] | ||||
Introduced Variation | Knockout of KMT2D | |||||
Induced Change | Citric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of KMT2D leads to the increase of citric acid levels compared with control group. | |||||
Isoprenylcysteine carboxylmethyltransferase (ICMT) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[13] | ||||
Introduced Variation | Inhibition (Cysmethynil) of ICMT | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] ... | |||||
Details | It is reported that inhibition of ICMT leads to the decrease of citric acid levels compared with control group. | |||||
Lipoyl synthase (LIAS) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Knockout of LIAS | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
Details | It is reported that knockout of LIAS leads to the decrease of citric acid levels compared with control group. | |||||
Pyridoxal kinase (PDXK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[14] | ||||
Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of PDXK | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
Details | It is reported that knockout of PDXK leads to the decrease of citric acid levels compared with control group. | |||||
Pyruvate kinase M2 (PKM) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[15] | ||||
Introduced Variation | Knockdown (shRNA) of PKM | |||||
Induced Change | Citric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockdown of PKM leads to the increase of citric acid levels compared with control group. | |||||
SNF-related serine/threonine-protein kinase (SNRK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[16] | ||||
Introduced Variation | Knockdown (shRNA) of SNRK | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of SNRK leads to the decrease of citric acid levels compared with control group. | |||||
Succinyl CoA:3-oxoacid CoA transferase (SCOT) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Overexpression of OXCT1 | |||||
Induced Change | Citric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that overexpression of OXCT1 leads to the increase of citric acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Knockdown (shRNA) of OXCT1 | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that knockdown of OXCT1 leads to the decrease of citric acid levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.